Fundraising FoxIMO Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Modern Synthesismodernsynthesis.cominJan 2022✓ verified
Modern Synthesis is a biotechnology company that grows microbially-derived biomaterials from bacterial nanocellulose to replace animal leather and plastic-based synthetic textiles.
BiotechCircular EconomyNew MaterialsLondon, GB
Jen Keane(Co-founder & CEO)inBen Reeve(Co-founder & CTO)inLouis Graham(Founder)in
Co-investorsArtesianCollaborative FundExtantia CapitalAcequia Capital (AceCap)AgFunderPonderosa Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.